| Product Code: ETC9524857 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import shipments of viral vectors and plasmid DNA in 2024 continued to be dominated by key exporters including the United States, Netherlands, Brazil, United Kingdom, and India. Despite a high concentration of Herfindahl-Hirschman Index (HHI), indicating market dominance, there was a significant decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024 at -26.83%. The growth rate from 2023 to 2024 experienced a steep decline of -67.36%, reflecting potential shifts in market dynamics and demand for these biotechnological products in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Viral Vectors and Plasmid DNA Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Viral Vectors and Plasmid DNA Market - Industry Life Cycle |
3.4 Suriname Viral Vectors and Plasmid DNA Market - Porter's Five Forces |
3.5 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Suriname Viral Vectors and Plasmid DNA Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for gene therapy and genetic research in Suriname |
4.2.2 Technological advancements in viral vectors and plasmid DNA research |
4.2.3 Growing investments in biotechnology and pharmaceutical industries in Suriname |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for gene therapy and DNA research in Suriname |
4.3.2 Limited availability of skilled professionals in the field of viral vectors and plasmid DNA |
4.3.3 High costs associated with research and development of viral vectors and plasmid DNA in Suriname |
5 Suriname Viral Vectors and Plasmid DNA Market Trends |
6 Suriname Viral Vectors and Plasmid DNA Market, By Types |
6.1 Suriname Viral Vectors and Plasmid DNA Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Plasmid DNA, 2022 - 2032F |
6.1.4 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Vectors, 2022 - 2032F |
6.1.5 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Non-viral Vectors, 2022 - 2032F |
6.2 Suriname Viral Vectors and Plasmid DNA Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Cancers, 2022 - 2032F |
6.2.3 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Inherited Disorders, 2022 - 2032F |
6.2.4 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Infections, 2022 - 2032F |
6.2.5 Suriname Viral Vectors and Plasmid DNA Market Revenues & Volume, By Others, 2022 - 2032F |
7 Suriname Viral Vectors and Plasmid DNA Market Import-Export Trade Statistics |
7.1 Suriname Viral Vectors and Plasmid DNA Market Export to Major Countries |
7.2 Suriname Viral Vectors and Plasmid DNA Market Imports from Major Countries |
8 Suriname Viral Vectors and Plasmid DNA Market Key Performance Indicators |
8.1 Research and development expenditure in the biotechnology sector in Suriname |
8.2 Number of clinical trials utilizing viral vectors and plasmid DNA in Suriname |
8.3 Adoption rate of gene therapy techniques in medical institutions in Suriname |
9 Suriname Viral Vectors and Plasmid DNA Market - Opportunity Assessment |
9.1 Suriname Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Suriname Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Suriname Viral Vectors and Plasmid DNA Market - Competitive Landscape |
10.1 Suriname Viral Vectors and Plasmid DNA Market Revenue Share, By Companies, 2025 |
10.2 Suriname Viral Vectors and Plasmid DNA Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here